S&E Bio
Seoul
About S&E Bio
S&E Bio is a biopharmaceutical company that develops cell therapies for neurological disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $7.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2022)
- Website: snebio.com
- Phone: +82 02 2054 8128
Industries & Categories
Biotechnology, Medical, Neuroscience, Pharmaceutical
Canonical: https://fsome.com/organization/s-e-bio-3749 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.